Streetbeat News

Stock Prices

BCRX

BioCryst Pharmaceuticals' ORLADEYO shows significant reductions in healthcare resource utilization for hereditary angioedema patients, including fewer hospitalizations and emergency visits. The study will be presented at the AMCP Nexus 2024 meeting.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 11:08 am

UNCY

Unicycive Therapeutics, Inc. (NASDAQ:UNCY) will present new research on its kidney disease therapies at ASN Kidney Week 2024. The company will showcase findings on oxylanthanum carbonate (OLC) and UNI-494, highlighting their potential benefits for patients with chronic kidney disease. Unicycive is seeking FDA approval for OLC, which has shown promising results in clinical trials.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 11:05 am

IVA

LBPH

MTEM

TVGN

VEV

XPON

Longboard Pharmaceuticals shares surged 46.8% in pre-market trading after Lundbeck agreed to acquire the company for approximately $2.6 billion. Other notable pre-market movers include Inventiva, Tevogen Bio, and Expion360, which saw significant gains, while Molecular Templates and Vicinity Motor experienced sharp declines.

Portfolio Pulse from Avi Kapoor

October 14, 2024 | 11:04 am

ACI

FXG

Albertsons Companies, Inc. (NYSE:ACI) has recalled 12 types of ReadyMeals and deli items due to potential Listeria contamination. The recall affects multiple states and was initiated after contamination was detected in a chicken ingredient. Albertsons recently launched an innovative wine bottle made from recycled PET. ACI shares are slightly up premarket.

Portfolio Pulse from Lekha Gupta

October 14, 2024 | 11:01 am

QQQ

SIRI

SPY

TSLA

U.S. stock futures are showing mixed signals ahead of the Q3 earnings season. The SPDR S&P 500 ETF Trust (SPY) and Invesco QQQ ETF (QQQ) are up in premarket trading. Tesla (TSLA) and Sirius XM (SIRI) see gains, while Boeing (BA) faces a decline due to workforce cuts. Analysts suggest a strong market outlook post-election.

Portfolio Pulse from Shanthi Rexaline

October 14, 2024 | 10:59 am

BLK

JPM

SPY

USO

UUP

WFC

U.S. markets closed positively with financial stocks leading gains after major banks reported strong earnings. JPMorgan, Wells Fargo, and BlackRock exceeded profit expectations, boosting the S&P Financials index. This, along with favorable inflation data, raised hopes for a potential Federal Reserve rate cut in November. Meanwhile, oil prices fell due to demand concerns, and the U.S. dollar strengthened.

Portfolio Pulse from Akanksha Bakshi

October 14, 2024 | 10:50 am

LLY

Eli Lilly's drug mirikizumab shows promising results in a Phase 3 study for Crohn's disease, outperforming ustekinumab in achieving histologic response at Week 52. The study is significant for its systematic assessment of bowel segments and adherence to ECCO guidelines.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 10:47 am

ABT

BAC

JNJ

QQQ

SPY

TSM

UNH

Columbus Day on October 14, 2024, will see the NYSE and Nasdaq open, while bond markets will be closed. Major companies like UnitedHealth, Johnson & Johnson, Bank of America, Abbott Laboratories, and TSMC will release earnings reports. SPY and QQQ showed slight pre-market gains.

Portfolio Pulse from Benzinga Neuro

October 14, 2024 | 10:46 am

LBPH

Lundbeck has agreed to acquire Longboard Pharmaceuticals for approximately $2.6 billion in equity value. The deal offers Longboard shareholders $60 per share, a 77% premium over the 30-day VWAP as of September 30, 2024. The transaction is expected to close in Q4 2024, pending regulatory approvals.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 10:32 am

HIW

Highwoods Properties announced that its buildings have not sustained any notable damage from Hurricane Milton, which is positive news for the company and its investors.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 10:08 am